The Drug Enforcement Administration is accepting comments through Oct. 4 on a proposal to add the central nervous stimulant methiopropamine (N-methyl-1-(thiophen-2-yl)propan-2-amine), including its salts, isomers, and salts of isomers, to schedule I of the Controlled Substances Act. This rule would impose the administrative, civil, and criminal sanctions and regulatory controls applicable to schedule I substances on the importation, exportation, manufacture, distribution, possession, research, conduct of instructional activities, and chemical analysis of this substance.
Copyright © 2024 Sandler, Travis & Rosenberg, P.A.; WorldTrade Interactive, Inc. All rights reserved.